Illinois Gov. JB Pritzker disclosed that he lost 80 pounds after being diagnosed with Type 2 diabetes two years ago and beginning treatment with a GLP-1 medication. The governor stated that the combination of the drug, improved diet, and exercise has allowed him to discontinue insulin and return to non-diabetic health levels. This marks the first time Pritzker has publicly confirmed both his diabetes diagnosis and his use of the medication class, which has become a prominent topic in national health and political discourse.
What the Right Is Saying
Conservative commentators and political rivals have long used Pritzker’s physical appearance as a point of critique, with former President Donald Trump frequently making comments about the governor's weight. The disclosure provides a factual counterpoint to these attacks, shifting the conversation from aesthetics to medical necessity. Pritzker had previously sidestepped questions about his weight, telling POLITICO in 2025, "How about, just for health," but the specific details of his diagnosis and treatment were kept private until now.
Republican critics often frame the broader GLP-1 trend as a lifestyle choice rather than a medical intervention, questioning the cost to public health systems. However, Pritzker’s case, which involves a confirmed Type 2 diabetes diagnosis and the removal of insulin dependency, complicates the argument that such medications are solely for cosmetic weight loss. The governor's office confirmed that his health markers, including cholesterol and triglycerides, have improved significantly, providing data that may challenge skeptical narratives about the efficacy and necessity of the drug for diagnosed diabetics.
What the Left Is Saying
Progressive voices and Democratic supporters have largely framed Pritzker’s disclosure as a move toward transparency and destigmatization of GLP-1 usage. Pritzker emphasized the personal health stakes, recounting that doctors warned he would require insulin for the rest of his life if he did not intervene. "My doctor said, 'Oh no, you’ll never come off of it. You’re going to have to do this the rest of your life, and I recommend that you take a GLP-1,'" Pritzker said, as reported by CBS News. His wife, MK Pritzker, supported the decision, stating, "I want him to be around for a really long time."
Pritzker also highlighted the policy implications of his treatment, noting his pride in Illinois' decision to cover GLP-1 medications for residents with diabetes. He described becoming emotional after a constituent told him that access to the medication had saved her life. This narrative aligns with Democratic efforts to expand healthcare access and reduce the financial burden of newer diabetes and weight-loss treatments. The governor's visibility in discussing his health journey is seen by allies as a way to normalize the use of these drugs among working-class Americans who may face barriers to access.
What the Numbers Show
Pritzker, 61, lost 80 pounds since starting the medication two years ago. His physician’s recommendation came after a Type 2 diabetes diagnosis, with the warning that he would likely need lifelong insulin therapy. According to his office, Pritzker is "no longer on insulin and down to levels that indicate no diabetes/prediabetic levels." The governor struggled with weight since childhood, a period marked by the death of his father, Donald Pritzker, who suffered a fatal heart attack at age 39. Pritzker has monitored his health markers closely due to this family history.
The disclosure comes as Pritzker chairs a political action committee investing at least $20 million in Democratic House races for the 2026 midterms. This financial commitment has intensified speculation about a potential 2028 presidential run. During a Gridiron Club dinner earlier this year, Pritzker acknowledged public curiosity about his appearance, joking, "If you’re seeing me in person for the very first time, yes, I’m the guy who put ‘gov’ in ‘Wegovy.'" He currently exercises by walking along the Lake Michigan path, a habit he says also allows him to connect with constituents.
The Bottom Line
Pritzker’s disclosure places the debate over GLP-1 medication coverage and access at the center of his emerging national political profile. As he takes a more prominent role in the 2026 midterms and faces speculation about a 2028 presidential bid, his health narrative serves both as a personal defense against past criticisms and as a potential policy platform for expanding healthcare access. The governor has stated he remains focused on "what's best for the people of Illinois," but the increased scrutiny of his stamina and health management will likely continue as he engages in national politics.